Articles tagged with Bactericidal Antibiotics
A team of scientists at the University of Sydney has discovered how three naturally occurring antibiotic compounds disrupt the ClpC1–ClpP1P2 complex, a vital protein degradation machine in Mycobacterium tuberculosis. This finding uncovers surprising complexity and provides valuable insight into designing more effective anti-TB treatments.
Researchers studied Norwegians with reported chronic health problems linked to tick bites, finding no objective evidence of persistent infections. The study suggests that physical activity and labour force participation may be more related to symptoms than tick exposure.
A one- and three-month antibiotic treatment regimens both had few adverse reactions and high rates of completion in preventing active tuberculosis, says a new study published in PLOS Medicine. The regimens were deemed successful and neither proved superior to the other.
The Ann Arbor Guide provides two algorithms for triaging adults with suspected UTIs, one for non-pregnant women and the other for men. It also emphasizes the importance of accurate testing and treatment to prevent overuse of antibiotics and antibiotic resistance.
A team of researchers has identified two proteins critical to the destruction of red blood cells by the Oroya fever pathogen. This discovery paves the way for a potential novel therapy against this deadly neglected tropical disease.
Researchers at UMC Utrecht discovered that converting monoclonal antibodies from IgG to IgM isotype can significantly broaden their ability to recognize and bind multiple human-relevant bacterial pathogens. This finding could guide the future design of antibody therapies against bacterial infections.
A study analyzed antibiotic prescribing patterns in Arkansas Medicaid's patient-centered medical home (PCMH) program. The results showed a decrease in pediatric and adult age group claims, with clinics that prescribed the least antibiotics having lower rates in 2021 compared to previous years.
Research from the University of South Australia finds that ibuprofen and paracetamol drive antibiotic resistance when used individually, but amplifying it when combined. The study also reveals that common bacteria like E. coli become highly resistant to antibiotics and multiple other medications.
The book examines antibiotic-induced reproductive toxicity, microbiome alterations, and emerging concerns around antibiotic resistance. It provides critical insights for clinicians, pharmacists, researchers, and students in reproductive medicine and pharmacology.
A new study published in Nature reveals that maintaining a healthy diet is the most effective way to rebuild a depleted gut microbiome, outperforming fecal transplants. The research shows that a Western-style diet can severely impact the microbiome's ability to defend against pathogens.
Scientists at HIRI develop peptide nucleic acid-based compound FUS79, which inhibits Fusobacterium nucleatum growth and exhibits strong activity against five fusobacterial strains without affecting other bacteria. This breakthrough has potential to accelerate research in targeted antibiotics for cancer treatment.
Researchers have discovered a new class of natural antimicrobials called microcins that can target specific strains of bacteria causing cholera, inflammatory bowel disease, and colon cancer. Microcins are highly selective and can potentially remove unwanted bacteria without disrupting the human gut microbiome.
A study by Dr. Takanori Sekito and colleagues reveals a strong association between vaginal pathogenic Escherichia coli and recurrent cystitis in postmenopausal women, suggesting that targeting both the urinary bladder and vagina is crucial for effective treatment.
Researchers at Utrecht University have discovered a new mechanism by which the antibiotic plectasin traps bacteria using a 'Velcro'-like structure. This innovative approach could lead to the development of more effective antibiotics to combat antimicrobial resistance.
A researcher will study how plants defend themselves against nematode infections, which could lead to novel drugs or antibiotics for humans and livestock. The project aims to increase food security in Africa and Asia by understanding the molecular mechanisms behind plant resistance.
Researchers have developed a new class of antibiotics that can overcome drug-resistant bacteria by targeting the physical and functional integrity of the bacterial cell wall. This could be a game-changer in treating infections, particularly those caused by resistant strains.
A University of Melbourne research team is developing an oral therapeutic to restore the activity of common antibiotics used to treat community-acquired bacterial pneumonia. The project aims to combat antibiotic-resistant bacteria and reduce healthcare costs, with potential applications in low- and middle-income countries.
Outpatient antibiotic prescribing in Australia decreased significantly during the pandemic, with a 38% drop in winter 2020 compared to pre-pandemic years. The reduction was predominantly due to decreases in GP prescribing and targeted public education efforts.
UC Riverside scientists developed a technique to map tryptophan production, opening the door to new treatment drugs. By understanding how bacteria make tryptophan, researchers can create enzymes that shut down this process, killing invasive bacterial cells without affecting human cells.
A study by Anglia Ruskin University has identified potentially dangerous Pseudomonas bacteria in 21% of wild bird faeces collected from locations near the River Cam. The bacteria, which can be passed on to humans through cross-contamination, were resistant to multiple antibiotics.